4Laufs U, Gertz K, Dirnagl U, et al. Rosuvastatin, a new HMG -CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemie stroke in mice[J]. Brain Res, 2002,942 : 23 - 30.
6Shindo H, Tawata M, Tnoue M, et al. The effect of prostag landin El. ACD on vibratory theshould determinded with the SMV- 5 vibrometer in patients with diabetic neuropathy[J]. Diabetes Res Clin Pract, 1994,24 : 173 - 180.
3Lango R, Smolenski RT, Narkiewicz M, et al. Influence of L-carnitine and its derivatives on myocardial metabolism and function in ischemic heart disease and during cardiopulmonary bypass. Cardiovasc Res,2001,51:21-29.
4Maritim AC,Sanders RA,Watkins JB 3rd. Effects of alpha-lipoicacid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem, 2003,14: 288-294.
5Bitar MS, Wahid S, Pilcher CW, et al. Alpha-lipoic acid mitigates insulin resistance in Goto-Kakizaki rats. Horm Metab Res,2004,36:542-549.
6Da Ros R, Assaloni R, Ceriello A. The preventive anti-oxidant action of thiazolidinediones: a new therapeutic prospect in diabetes and insulin resistance. Diabet Med,2004,21:1249-1252.
8Ceriello A, Taboga C, Tonutti L, et al. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation, 2002,106:1211 -1218.
9Takemoto M, Node K, Nakagami H, et al. Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest, 2001, 108:1429-1437.
10Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 2005,54:1615-1625.
